# EDGAR Filing Document

**Accession Number:** 0002019003
**File Stem:** 0000943819-26-000029
**Filing Date:** 2026-5
**Character Count:** 9946
**Document Hash:** 34efda8f8dc609403fa220eaa389d851
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000943819-26-000029.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0000943819-26-000029

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260504

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bloomer Aaron
- **CENTRAL INDEX KEY:** 0002019003

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15317
- **FILM NUMBER:** 26939527

**MAIL ADDRESS:**
- **STREET 1:** C/O EXACT SCIENCES CORP.
- **STREET 2:** 5505 ENDEAVOR LANE
- **CITY:** MADISON
- **STATE:** WI
- **ZIP:** 53719
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RESMED INC
- **CENTRAL INDEX KEY:** 0000943819
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980152841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123
- **BUSINESS PHONE:** 8587462400

**MAIL ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123

## Ex-24

```

POWER OF ATTORNEY

The undersigned hereby makes, constitutes and appoints each of Lisa Beyer,
Julie Hutt, Joseph Yim,
Michael Rider, Gladimera Gaditano and Michelle Betancourt,
or either of them acting singly, and with full power of substitution,
re-substitution and delegation, the undersigned?s true and
lawful attorney in fact (each of such persons and their substitutes and
delegees being referred to herein as the ?Attorney-in-Fact?),
with full power to act for the undersigned and in the undersigned?s name,
place and stead, in the undersigned?s capacity as an officer,
director or stockholder of ResMed Inc. (the ?Company?), to:

1. Take such actions as may be necessary or appropriate to enable
	the undersigned to submit and file forms, schedules and other documents
	with the U.S. Securities and Exchange Commission (?SEC?)
	utilizing the SEC?s Electronic Data Gathering and Retrieval (?EDGAR?) system,
	which actions may include (a) enrolling the undersigned in
	EDGAR Next and (b) preparing, executing and submitting to the
	SEC a Form ID, amendments thereto, and such other documents
	and information as may be necessary or
	appropriate to obtain codes and passwords enabling the
	undersigned to make filings and submissions
	utilizing the EDGAR system;

	2. Prepare and execute any and all forms, schedules and
	other documents (including any amendments thereto)
	the undersigned is required to file with the SEC,

	considers it advisable for the undersigned to file with the SEC,
	under Section 13 or Section 16 of the Securities Exchange Act of 1934
	or any rule or regulation thereunder, or under Rule 144 under the Securities
	Act of 1933 (?Rule 144?), including Forms 3, 4 and 5,
	Schedules 13D and 13G, and Forms 144 (all such forms, schedules and
	other documents being referred to herein as ?SEC Filings?);

	3. Submit and file SEC Filings with the SEC utilizing the EDGAR system
	or cause them to be submitted and filed by a person appointed
	under Section 5 below;

	4. File, submit or otherwise deliver SEC Filings to any securities exchange
	on which the  Company?s securities may be listed or traded;

	5. Act as an account administrator for the undersigned?s EDGAR account,
	including: (i) appoint, remove and replace account administrators,
	account users, technical administrators and delegated entities;
	(ii) maintain the security of the undersigned?s EDGAR account, including
	modification of access codes; (iii) maintain, modify and certify
	the accuracy of information on the undersigned?s EDGAR account
	dashboard; (iv) act as the EDGAR point of contact
	with respect to the undersigned?s EDGAR account; and
	(v) any other actions contemplated by Rule 10 of Regulation
	S-T with respect to account administrators;

	6. Cause the Company to accept a delegation of authority from any
	of the undersigned?s EDGAR account administrators and,
	pursuant to that delegation, authorize the Company?s EDGAR
	account administrators to appoint, remove or replace users
	for the undersigned?s EDGAR account; and

	7. Obtain, as the undersigned?s representative and
	on the undersigned?s behalf, information
	regarding transactions in the Company?s
	equity securities from any third party, including the Company and
	any brokers, dealers, employee benefit plan administrators
	and trustees, and the undersigned hereby authorizes any such third party
	to release any such information to the Attorney-in-Fact.

	The undersigned acknowledges that:

		a. This Power of Attorney authorizes, but does not require,
	the Attorney-in-Fact to act in his or her discretion on
	information provided to such Attorney-in-Fact
	without independent  verification of such information;

		b. Any documents prepared or executed by the Attorney-in-Fact
	on behalf of the undersigned pursuant to this Power of Attorney
	will be in such form and will contain such information
	as the Attorney-in-Fact, in his or her discretion,
	deems necessary or desirable;

		c. Neither the Company nor the Attorney-in-Fact assumes
	any liability for the undersigned?s responsibility to comply
	with the requirements of Section 13 or Section 16 of the
	Exchange Act or Rule 144, any liability of the undersigned for
	any failure to comply with such requirements,
	or any liability of the undersigned for disgorgement
	of profits under Section 16(b) of the Exchange Act; and

	d. This Power of Attorney does not relieve the undersigned
	from responsibility for compliance with the undersigned?s
	obligations under Section 13 or Section 16
	of the Exchange Act, including, without limitation,
	the reporting requirements under Section 13 or
	Section 16 of the Exchange Act.

The undersigned hereby grants to the Attorney-in-Fact full power and authority
every act and thing requisite, necessary or advisable to be done
in connection with the foregoing, as fully, to all intents and purposes,
as the undersigned might or could do in person, hereby ratifying and confirming
all that the Attorney-in-Fact, or his or her substitute or substitutes,
shall lawfully do or cause to be done by authority of this Power of Attorney.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 4 or 5 or Schedules 13D or 13G
or Forms 144 with respect to the undersigned?s holdings of and transactions
in securities of the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the Attorney-in-Fact. This Power of Attorney revokes
all previous powers of attorney with respect to the subject matter
of this Power of Attorney.

[Signature Page to Follow]

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney
as of May 4, 2026.

Signature
/s/ AARON BLOOMER
Print Name

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bloomer Aaron<br><sub>(Last) (First) (Middle)</sub><br>RESMED INC.<br>9001 SPECTRUM CENTER BLVD.<br><sub>(Street)</sub><br>SAN DIEGO, CA 92123<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>RESMED INC [ RMD ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-04 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Signature:** /s/ Michael J. Rider, attorney-in-fact for Mr. Bloomer  
**Date:** 2026-05-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**